Minoru Hasegawa

Summary

Affiliation: Kanazawa University
Country: Japan

Publications

  1. ncbi The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer
    Yuki Saito
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    J Invest Dermatol 128:1838-51. 2008
  2. ncbi Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
    M Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920 8641, Japan
    Ann Rheum Dis 64:21-8. 2005
  3. ncbi The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Front Biosci 13:3637-47. 2008
  4. ncbi Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Dermatol Sci 39:1-7. 2005
  5. ncbi Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Rheumatology (Oxford) 51:129-33. 2012
  6. ncbi A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arthritis Rheum 60:3465-75. 2009
  7. ncbi Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis
    M Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Ann Rheum Dis 63:1514-7. 2004
  8. ncbi B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920 8641, Japan
    J Dermatol 37:3-10. 2010
  9. ncbi Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arch Dermatol Res 296:89-93. 2004
  10. ncbi Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma
    M Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Clin Exp Rheumatol 24:19-24. 2006

Collaborators

Detail Information

Publications99

  1. ncbi The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer
    Yuki Saito
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    J Invest Dermatol 128:1838-51. 2008
    ..We propose that this is a useful model for investigating the mechanism of pressure ulcer formation using various transgenic mice...
  2. ncbi Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
    M Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920 8641, Japan
    Ann Rheum Dis 64:21-8. 2005
    ..Fractalkine expressed on endothelial cells mediates activation and adhesion of leucocytes expressing its receptor, CX(3)CR1. Soluble fractalkine exhibits chemotactic activity for leucocytes expressing CX(3)CR1...
  3. ncbi The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Front Biosci 13:3637-47. 2008
    ..Here recent data will be reviewed on the pathogenic role of chemokines and their receptors in SSc...
  4. ncbi Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Dermatol Sci 39:1-7. 2005
    ..Thus, altered B cell function may result in tissue fibrosis, as well as autoimmunity, in SSc...
  5. ncbi Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Rheumatology (Oxford) 51:129-33. 2012
    ..It is well known that ethnic variations exist in the clinical features and severity of SSc. However, neither the clinical course nor prognostic factors have been thoroughly investigated in the Japanese population...
  6. ncbi A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arthritis Rheum 60:3465-75. 2009
    ....
  7. ncbi Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis
    M Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Ann Rheum Dis 63:1514-7. 2004
    ..To determine the frequency and clinical association of antiphosphatidylserine-prothrombin complex (PS/PT) antibody (Ab) in systemic sclerosis (SSc)...
  8. ncbi B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920 8641, Japan
    J Dermatol 37:3-10. 2010
    ..As B cells have a variety of functions, further investigation into the pathogenic roles of B cells, as well as trials of B-cell-targeting therapies, may shed new light on the pathogenesis of SSc...
  9. ncbi Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arch Dermatol Res 296:89-93. 2004
    ..Thus, the enhanced production of TGF-beta by PBMC may contribute to the disease process in SSc..
  10. ncbi Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma
    M Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Clin Exp Rheumatol 24:19-24. 2006
    ..We investigated anti-PS/PT Ab levels in patients with LSc...
  11. ncbi Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa, 920 8641, Japan
    Clin Rheumatol 30:231-7. 2011
    ..However, a longer-term prospective study in a larger population will be needed to confirm its clinical utility as predictors of outcomes...
  12. ncbi Dermoscopy findings of nail fold capillaries in connective tissue diseases
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Dermatol 38:66-70. 2011
    ..In this review, I summarized the established capillaroscopy findings in connective tissues diseases and tried to apply the findings of dermoscopy to the findings and classification of capillaroscopy...
  13. ncbi Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa, Japan
    J Rheumatol 38:877-84. 2011
    ....
  14. ncbi Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Dermatology 207:141-7. 2003
    ..The enhanced production of some cytokines may be related to the pathogenesis of localized scleroderma (LSc)...
  15. ncbi Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model
    Ayumi Yoshizaki
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Immunol 185:2502-15. 2010
    ....
  16. ncbi Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice
    Yukiyo Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Immunol 179:698-707. 2007
    ..Thus, our findings indicate that ICAM-1 expression contributes to the development of skin fibrosis in TSK/+ mice, especially via ICAM-1 expressed on skin fibroblasts...
  17. ncbi Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction
    Toshihide Hara
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852 8501, Japan
    Am J Pathol 176:259-69. 2010
    ....
  18. ncbi Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction
    Takayuki Ishii
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Am J Pathol 174:2225-33. 2009
    ..The IgE-mediated cutaneous reverse passive Arthus reaction may serve as an experimental model for cutaneous eosinophilic infiltration in vasculitis as well as in other diseases...
  19. ncbi B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Japan
    Am J Pathol 169:954-66. 2006
    ..Thereby, B-cell depletion during disease onset suppressed skin fibrosis, indicating that B cells contribute to the initiation of systemic sclerosis pathogenesis in tight-skin mice but are not required for disease maintenance...
  20. ncbi The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity
    Asako Ogawa
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki, Japan
    J Invest Dermatol 130:1558-70. 2010
    ..These results suggest that ICAM-1 mediates Th1 cell recruitment irrespective of DNFB or FITC and that L-selectin recruits Th1 cells in Th1-type CHS, whereas it recruits Th2 cells in Th2-type CHS...
  21. ncbi Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1
    Toru Yukami
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1, Takara machi, Kanazawa 920 8641, Japan
    J Leukoc Biol 82:519-31. 2007
    ..These results indicate that skin wound healing is regulated cooperatively by all selectins and ICAM-1 and may provide critical information for the therapy of skin wounds...
  22. ncbi P-selectin glycoprotein ligand-1 contributes to wound healing predominantly as a p-selectin ligand and partly as an e-selectin ligand
    Hajime Tomita
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Invest Dermatol 129:2059-67. 2009
    ..These results suggest that PSGL-1 contributes to wound healing predominantly as a P-selectin ligand and partly as an E-selectin ligand by mediating infiltration of inflammatory cells...
  23. ncbi Low zone tolerance requires ICAM-1 expression to limit contact hypersensitivity elicitation
    Kazuhiro Komura
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto, Nagasaki, Japan
    J Invest Dermatol 129:2661-7. 2009
    ..These results indicate that low-dose tolerization controls CHS by abrogating ICAM-1 upregulation during the elicitation phase...
  24. ncbi E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis
    Mayuka Horikawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Am J Pathol 169:740-9. 2006
    ..These results suggest that E- and P-selectins synergistically inhibit lung fibrosis by promoting the recruitment of NKT cells...
  25. ncbi L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity
    Yuka Shimada
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Immunol 170:4325-34. 2003
    ....
  26. ncbi Increased serum pentraxin 3 in patients with systemic sclerosis
    Yohei Iwata
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 36:976-83. 2009
    ..To determine serum concentrations of pentraxin 3 (PTX3) and its clinical associations in patients with systemic sclerosis (SSc)...
  27. ncbi Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site
    Kazuhiro Komura
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    J Immunol 171:2855-62. 2003
    ..These results indicate that UV exposure inhibits CHS by abrogating up-regulation of endothelial ICAM-1 expression after Ag challenge at elicitation sites...
  28. ncbi CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma
    Ayumi Yoshizaki
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki, 852 8501, Japan
    Am J Pathol 172:1650-63. 2008
    ....
  29. ncbi Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 cooperatively contribute to the cutaneous Arthus reaction
    Hidemitsu Orito
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    J Leukoc Biol 81:1197-204. 2007
    ..Thus, VCAM-1 plays a complementary role to ICAM-1 in the cutaneous Arthus reaction by regulating leukocyte accumulation and proinflammatory cytokine production...
  30. ncbi Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses
    Tomoyuki Fujita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Am J Pathol 170:1649-58. 2007
    ..Collectively, P- and E-selectins cooperatively regulate CH response, although their roles may be different depending on the phase of the reaction...
  31. ncbi Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies
    Takamasa Wayaku
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Rheumatol Int 28:113-9. 2007
    ..The antigenic stimulus in SLE may be different from other connective tissue diseases and is more likely to be native chromatin...
  32. ncbi Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis
    Masanari Kodera
    Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arthritis Rheum 52:2889-96. 2005
    ..CONCLUSION: Elevated serum PARC levels correlated with PF and more sensitively reflected the PF activity than did serum KL-6 or SP-D levels in SSc. Serum PARC levels may be a useful new serum marker for active PF in SSc...
  33. ncbi CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse
    Eriko Saito
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Clin Invest 109:1453-62. 2002
    ..CD19 deficiency also inhibited IL-6 production by TSK/+ B cells. Thus, chronic B cell activation resulting from augmented CD19 signaling in TSK/+ mice leads to skin sclerosis possibly through IL-6 overproduction as well as autoimmunity...
  34. ncbi Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity
    Ayumi Yoshizaki
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 35:1825-9. 2008
    ..To determine any clinical association of serum levels of hyaluronan in patients with systemic sclerosis (SSc)...
  35. ncbi Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis
    Yasuhito Hamaguchi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
    Am J Pathol 161:1607-18. 2002
    ..This suggests that these adhesion molecules are potential therapeutic targets for inhibiting human pulmonary fibrosis...
  36. ncbi Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis
    Hajime Tomita
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto, Nagasaki, Japan
    J Rheumatol 37:787-91. 2010
    ..To determine serum concentrations and clinical association of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in patients with systemic sclerosis (SSc)...
  37. ncbi Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis
    Koichi Yanaba
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 36:1917-23. 2009
    ..To determine serum concentrations of soluble CXCL16 and its clinical associations in patients with systemic sclerosis (SSc)...
  38. ncbi Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway
    Chihiro Tanaka
    Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Arthritis Rheum 62:1723-32. 2010
    ..Although the ICOS/ICOSL pathway is known to play various roles in adaptive immunity, its roles in innate immunity and tissue fibrosis remain unknown...
  39. ncbi Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid
    Makoto Inaoki
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    J Autoimmun 27:196-202. 2006
    ..These results suggest that a decrease in CD22 expression may not be associated with BP-specific antibody production...
  40. ncbi Increased serum soluble CD40 levels in patients with systemic sclerosis
    Kazuhiro Komura
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
    J Rheumatol 34:353-8. 2007
    ..To determine serum levels of soluble CD40 (sCD40) and clinical association in patients with systemic sclerosis (SSc)...
  41. ncbi Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage
    Fumihide Ogawa
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki 852 8501, Japan
    Arch Dermatol Res 302:27-35. 2010
    ..These results suggest that elevated anti-MSRA autoantibody is associated with the disease severity of SSc and may enhance the oxidative stress by inhibiting MSRA enzymatic activity...
  42. ncbi L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury
    Ayako Kawasuji
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1, Takara machi, Kanazawa, 920 8641, Japan
    J Leukoc Biol 79:696-705. 2006
    ..These results indicate that L-selectin and ICAM-1 contribute cooperatively to the development of Con A-induced hepatitis by regulating leukocyte infiltration and subsequent cytokine production...
  43. ncbi BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Invest Dermatol 127:2772-80. 2007
    ..The results suggest that BAFF/BAFF receptor system is critical for the development of skin fibrosis in TSK/+ mice and could be a potent therapeutical target...
  44. ncbi Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis
    Hidetaka Fujii
    Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    J Dermatol Sci 35:43-51. 2004
    ..Although abnormalities of various chemokines are detected in systemic sclerosis (SSc), there are few findings concerning Th1 or Th2 chemoattractants...
  45. ncbi Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Exp Dermatol 17:197-202. 2008
    ..These results suggest that elevated serum levels of APRIL are associated with disease severity and activity in AD, and APRIL may have an important role in the pathogenesis of AD...
  46. ncbi Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Am J Pathol 168:812-21. 2006
    ..Thus, CD19 modulates the Th1/Th2 cytokine balance in B cells and plays a critical role as a suppressive molecule in the development of EAE...
  47. ncbi Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity
    Ayumi Yoshizaki
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto, Nagasaki, Japan
    J Clin Immunol 29:180-9. 2009
    ..However, the association of this system in systemic sclerosis (SSc) remains unknown...
  48. ncbi Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis
    Shihoko Okazaki
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki, 852 8501, Japan
    Rheumatol Int 30:871-8. 2010
    ..These results suggest that autoantibody against caspase-3 is generated in SSc and that this Ab is related to the severity of pulmonary fibrosis, vascular damage, and inflammation...
  49. ncbi Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis
    Toshihide Hara
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 35:451-7. 2008
    ..To determine the prevalence and clinical significance of anti-p53 antibody in patients with systemic sclerosis (SSc)...
  50. ncbi Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis
    Yutaka Kuwatsuka
    Department of Dermatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
    Autoimmunity 42:120-5. 2009
    ..These results indicate the lack of anti-HDAC-3 autoantibody in SSc patients, which is produced in healthy individuals as well as DM and SLE patients, suggesting that this autoantibody might function as protective Ab...
  51. ncbi Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis
    Toshihide Hara
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki 852 8501, Japan
    J Rheumatol 36:99-105. 2009
    ..To determine the serum concentrations and clinical association of polymorphonuclear neutrophilic leukocyte (PMN) elastase in patients with systemic sclerosis (SSc)...
  52. ncbi CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling
    Yohei Iwata
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki, 852 8501, Japan
    Am J Pathol 175:649-60. 2009
    ..Thus, this study is the first to reveal a critical role of B cells and novel mechanisms in wound healing...
  53. ncbi Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation
    Ayumi Yoshizaki
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    Ann Rheum Dis 70:194-200. 2011
    ..To determine serum levels of interleukin 27 (IL-27) in patients with systemic sclerosis (SSc) and relate the results to the clinical features of SSc...
  54. ncbi Association between nail-fold capillary findings and disease activity in dermatomyositis
    Naoki Mugii
    Department of Rehabilitation, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
    Rheumatology (Oxford) 50:1091-8. 2011
    ..Our objective was to assess the changes and red blood cell velocity in finger nail-fold capillaries using nail-fold video capillaroscopy (NVC) in patients with adult-onset DM...
  55. ncbi Increased serum soluble OX40 in patients with systemic sclerosis
    Kazuhiro Komura
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 35:2359-62. 2008
    ..To determine levels of serum soluble OX40 (also termed CD134, a member of the tumor necrosis factor receptor superfamily) and their clinical associations in patients with systemic sclerosis (SSc)...
  56. ncbi Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis
    Takashi Matsushita
    Department of Dermatology and Division of Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 34:1012-8. 2007
    ..To investigate the distribution of anti-aminoacyl-tRNA synthetase (anti-ARS) antibodies among patients with autoimmune diseases, and to analyze the clinical features of patients with dermatomyositis (DM) with anti-ARS antibodies...
  57. ncbi Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis
    Ikuko Hayakawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan
    Arch Dermatol Res 297:180-3. 2005
    ..The results of the present study indicate that anti-topo II alpha Ab represent one of the autoantibody specificities detected on SSc patients and may be regarded a serological marker of pulmonary fibrosis in Japanese patients with SSc...
  58. ncbi Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation
    Takeshi Echigo
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    J Allergy Clin Immunol 113:940-8. 2004
    ..Fractalkine (FKN) induces activation and adhesion of leukocytes expressing its receptor, CX(3)CR1. FKN is released from the cell surface through proteolytic cleavage as soluble FKN (sFKN)...
  59. ncbi Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma
    Saori Tomimura
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki, Japan
    J Dermatol Sci 52:47-54. 2008
    ..Localized scleroderma (LSc) is characterized by cutaneous fibrosis and various autoantibodies...
  60. ncbi [Scleroderma]
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science
    Nippon Rinsho 63:295-9. 2005
  61. ncbi Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis
    Koichi Yanaba
    Department of Dermatology, Nagasaki University GraduateSchool of Biomedical Sciences, Nagasaki and Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 36:1657-62. 2009
    ..To determine serum levels of tumor necrosis factor-related weak inducer of apoptosis (TWEAK) and its clinical associations in patients with systemic sclerosis (SSc)...
  62. ncbi Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study
    Yasuhito Hamaguchi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arch Dermatol 147:391-8. 2011
    ..To clarify the association of clinical and prognostic features with dermatomyositis (DM)-specific autoantibodies (Abs) in adult Japanese patients with DM...
  63. ncbi Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity
    Mayuka Horikawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Invest Dermatol 125:731-7. 2005
    ..These results suggested that altered NK cell function contributes to immunological abnormalities in SSc...
  64. ncbi Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases
    Takeshi Echigo
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa 920 8641, Japan
    Arch Dermatol Res 298:38-45. 2006
    ..These results suggest that both a Th1 chemoattractant MIG and Th2 chemoattractants, TARC and MDC, cooperatively play a role in the development of ABD...
  65. ncbi Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Japan
    J Rheumatol 33:275-84. 2006
    ..CONCLUSION: These results suggest that a shift from Th2 to Th1 response correlates with improvement in skin fibrosis in SSc, and that IL-12 level is a serologically useful marker for disease activity and prognosis...
  66. ncbi Antiphospholipid antibodies in patients with autoimmune blistering disease
    Takeshi Echigo
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa 920 8641, Japan
    J Am Acad Dermatol 57:397-400. 2007
    ..Our purpose was to determine the serum levels and frequency of antiphospholipid antibodies (aPLs) and confirm the clinical importance of these antibodies in patients with autoimmune blistering disease (ABD)...
  67. ncbi The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression
    Yuko Kaburagi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Immunol 168:2970-8. 2002
    ....
  68. ncbi Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis
    Shinichi Sato
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13 1 Takaramachi, Kanazawa, Ishikawa 920 8641, Japan
    Mol Immunol 41:1123-33. 2004
    ..Thus, chronic B cell activation resulting from augmented CD19 signaling leads to skin fibrosis possibly through IL-6 overproduction, as well as autoantibody production, in tight-skin mice and SSc patients...
  69. ncbi Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma
    Masaki Nagai
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Invest Dermatol 122:594-601. 2004
    ....
  70. ncbi Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging
    Kenichi Nakajima
    Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920 8641, Japan
    Circ J 70:1481-7. 2006
    ....
  71. ncbi Esophageal transit scintigraphy and structured questionnaire in patients with systemic sclerosis with endoscopically proven reflux esophagitis
    Kenichi Nakajima
    Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Japan
    Ann Nucl Med 23:771-6. 2009
    ..The relationship between gastroesophageal reflux (GER) symptoms and dysmotility was examined in endoscopically confirmed patients suspected of having reflux esophagitis...
  72. ncbi Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells
    Shinichi Sato
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Arthritis Rheum 50:1918-27. 2004
    ..To determine phenotypic and functional abnormalities of blood B cell subsets in patients with systemic sclerosis (SSc)...
  73. ncbi Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis
    Yasuhito Hamaguchi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    J Am Acad Dermatol 62:142-4. 2010
    ..This case suggests a role for anti-topo I in the pathogenesis of systemic sclerosis and an effect of corticosteroids on skin sclerosis and autoantibody production...
  74. ncbi Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis
    Shinichi Sato
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Japan
    J Invest Dermatol 120:542-7. 2003
    ....
  75. ncbi Esophageal transit study using a sliding sum image: application to patients with probable and definite systemic sclerosis
    Kenichi Nakajima
    Department of Nuclear Medicine, Kanazawa University Hospital, 13 1 Takara machi, Kanazawa, 920 8641, Japan
    Ann Nucl Med 25:325-31. 2011
    ..The aim of this study was to develop a new algorithm for integrating a dynamic esophageal transit study and to apply the method to patients with SSc...
  76. ncbi Elevation of serum lymphotactin levels in patients with systemic sclerosis
    Eiji Muroi
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 35:834-8. 2008
    ..To determine serum concentrations of lymphotactin, a Th1 chemokine, and their clinical association in patients with systemic sclerosis (SSc)...
  77. ncbi Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis
    Yasuhito Hamaguchi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 35:2363-71. 2008
    ..To examine serum concentrations of insulin-like growth factor (IGF-1) and IGF binding protein (IGFBP-3), a major carrier protein for IGF-1, in patients with systemic sclerosis (SSc); and to relate the results to clinical features in SSc...
  78. ncbi Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis
    Ikuko Hayakawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Clin Rheumatol 23:345-7. 2004
    ..This case is very rare because such a case was not reported previously...
  79. ncbi Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis
    Koichi Yanaba
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 31:1112-20. 2004
    ..By contrast, KL-6 showed higher specificity than SP-D. Combined use of these 2 serum markers would be more helpful to diagnose and monitor the PF activity in patients with SSc than single use of each marker...
  80. ncbi Increased serum interleukin 23 in patients with systemic sclerosis
    Kazuhiro Komura
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    J Rheumatol 35:120-5. 2008
    ..We investigated serum IL-23 levels and their clinical association in patients with SSc...
  81. ncbi [B lymphocyte]
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science
    Nihon Rinsho Meneki Gakkai Kaishi 28:300-8. 2005
    ..This review focuses on recent data demonstrating the roles of B cells in autoimmune diseases as well as the current studies concerning the treatment of autoimmune diseases by Rituximab...
  82. ncbi Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes
    Takashi Matsushita
    Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arthritis Rheum 54:192-201. 2006
    ..CONCLUSION: These results suggest that BAFF and its signaling in B cells contribute to B cell abnormalities and disease development in patients with SSc...
  83. ncbi A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension
    Ikuko Hayakawa
    Department of Dermatology, Kanazawa University, Graduate School of Medical Science, 13-1 Takaramachi, Ishikawa 920-8641 Kanazawa, Japan
    Clin Rheumatol 23:266-8. 2004
    ..She was diagnosed as SSD with pulmonary hypertension. This is the first case of SSD with anticentriole antibody to develop pulmonary hypertension...
  84. ncbi Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Exp Dermatol 16:87-93. 2007
    ..By contrast, serum BAFF levels were not significantly elevated in patients with pemphigus or pemphigoid. These results suggest that BAFF may be contributing to autoimmunity and disease development in localized scleroderma...
  85. ncbi Elevated circulating CD40L concentrations in patients with systemic sclerosis
    Kazuhiro Komura
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 31:514-9. 2004
    ..CONCLUSION: Patients with SSc exhibited elevated sCD40L levels that may correlate with disease activity. These results suggest that CD40/CD40L interactions may be potential therapeutic targets in SSc...
  86. ncbi Mouse CD20 expression and function
    Junji Uchida
    Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA
    Int Immunol 16:119-29. 2004
    ..Thus, mouse and human CD20 share similar patterns of expression and function. These studies thereby provide an animal model for studying CD20 function in vivo and the molecular mechanisms that influence anti-CD20 immunotherapy...
  87. ncbi Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis
    Shinobu Furuse
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
    J Rheumatol 30:1524-8. 2003
    ....
  88. ncbi B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse
    Noriko Asano
    Department of Regenerative Medicine, Research Institute, International Medical Center of Japan, Tokyo, Japan
    Am J Pathol 165:641-50. 2004
    ....
  89. ncbi The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis
    Naoki Mugii
    Department of Dermatology and Division of Rehabilitation Science, Kanazawa University Hospital, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
    J Rheumatol 33:1586-92. 2006
    ....
  90. ncbi Clinical characteristics of juvenile systemic sclerosis in Japanese
    Maki Murata
    J Rheumatol 32:1850-2. 2005
  91. ncbi Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations
    Masanari Kodera
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 32:629-36. 2005
    ..CONCLUSION: Our results suggest that anti-LPL autoantibody contributes to elevated serum triglyceride levels by inhibiting LPL enzyme activity in patients with SSc...
  92. ncbi CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms
    Jonathan C Poe
    Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Nat Immunol 5:1078-87. 2004
    ..These observations resolve longstanding questions regarding the physiological importance of CD22 ligand binding in the regulation of B cell function in vivo...
  93. ncbi [Case of disseminated carcinomatosis of bone marrow with severe alkalinephosphatasia, manifested 10 years after resection of early gastric cancer]
    Michiaki Shiozaki
    The Second Department of Internal Medicine, Osaka Medical College
    Nippon Shokakibyo Gakkai Zasshi 101:879-84. 2004
  94. ncbi Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports
    Ikuko Hayakawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan
    Rheumatol Int 26:270-3. 2006
    ..We recognized no adverse events. We propose that oral sildenafil may be beneficial as a selective pulmonary vasodilator and as long-term treatment in SSc patients with isolated PAH...
  95. ncbi Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis
    Koki Hikami
    Doctoral Program in Life System Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1 1 1 Tennodai, Tsukuba, Ibaraki 305 8575, Japan
    Biochem Biophys Res Commun 373:403-7. 2008
    ..0019). Serum IL-10 level was significantly associated with the number of rs2834167A allele (P=0.007). These findings suggested that signaling through IL-10R2 may play a causative role in dcSSc...
  96. ncbi The roles of chemokines in the development of systemic sclerosis
    Minoru Hasegawa
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
    Nihon Rinsho Meneki Gakkai Kaishi 31:23-36. 2008
    ..Here recent data will be reviewed on the potential role of chemokines and their receptors in SSc...
  97. ncbi A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Dermatology 216:64-7. 2008
    ..Therefore, we administered psoralen-UVA (PUVA) therapy and achieved the desired therapeutic effect. As far as we know, this is the first case of psoriasiform skin eruption as a manifestation of acute GVHD...
  98. ncbi Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF
    Takashi Matsushita
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    J Rheumatol 34:2056-62. 2007
    ..We investigated serum levels of a proliferation-inducing ligand (APRIL), a close homolog to BAFF, and its clinical association in patients with SSc as well as its correlation with BAFF...
  99. ncbi Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma
    Ikuko Hayakawa
    Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    Arthritis Rheum 50:227-32. 2004
    ..CONCLUSION: The results of the present study indicate that anti-topo IIalpha is a major autoantibody in localized scleroderma, and is distinct from anti-topo I antibody in SSc...